Answers are grounded in this paper and cite their sources.
This editorial discusses the evolution and clinical performance of contemporary bioresorbable polymer drug-eluting stents, highlighting low event rates in real-world practice while emphasizing the need for tailored revascularization strategies to address residual risks.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Verdoia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: